Hours after US President Donald Trump announced broad tariffs on major US trading partners Canada, Mexico and China while ...
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries.
( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first ...
The FDA has approved Vertex Pharmaceuticals’ Journavx, a new pain medication designed to reduce the risk of addiction and overdose associated with opioids. Intended for short-term pain after surgeries ...
Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll ...
Application of a multi-stacked fentanyl patch could result in serious, life-threatening, or fatal respiratory depression.
U.S. needs to pursue evidence-based interventions for substance use disorders. It’s unclear to what degree the Trump ...
Doctors from the Cleveland Clinic talk about how this new non-opioid pain medication could help reduce the issue of opioid addiction in the United States.
Will people with acute pain want a new painkiller whose list price is $15.50 a pill when a generic prescription drug is at ...
Former Mesa County Commissioner Janet Rowland is leaving Mesa County for a new role in Montrose County as facilitator for the ...
The Food and Drug Administration has approved a first of its kind prescription pain medication that is non-opioid.